Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.26) by 6.46 percent. This is a 47.37 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $626.439 million which beat the analyst consensus estimate of $625.913 million by 0.08 percent. This is a 2.20 percent decrease over sales of $640.508 million the same period last year.